Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Sep;80(3):812–817. doi: 10.1172/JCI113138

Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.

B Egan, R Panis, A Hinderliter, N Schork, S Julius
PMCID: PMC442307  PMID: 3040806

Abstract

Multiple components of vascular alpha adrenergic responsiveness were investigated in twenty-four men with mild hypertension and eighteen age- and weight-matched normotensive controls. Arterial plasma norepinephrine (paNE), an index of sympathetic drive, was increased in hypertensives compared to normotensives (mean +/- SE), 199 +/- 24 vs. 134 +/- 11 pg/ml, P less than 0.02. The effective concentration of intra-arterial (iaNE) increasing forearm vascular resistance (FAVR) 30% (NE-EC30, an index of vascular alpha-receptor sensitivity) was similar in normotensives and hypertensives, 9 +/- 1 vs. 13 +/- 3 ng/100 ml per min, respectively, P greater than 0.3. The phentolamine induced reduction in FAVR, an index of vascular alpha-tone, was greater in hypertensives, -21.3 +/- 1.8 vs. normotensives, -14.9 +/- 1.2 U, P less than 0.02. We interpret these data as evidence for normal vascular alpha-receptor sensitivity to norepinephrine in mild hypertensives. Consequently, the increased sympathetic drive in mild hypertensives explains the elevated vascular alpha-tone. Although vascular alpha-receptor sensitivity to iaNE was normal, the FAVR responses at high doses (reactivity) were greater in hypertensives to regional infusion of both NE and angiotensin II. This "nonspecific" enhancement of vascular reactivity is probably explained by structural vascular changes in hypertensives.

Full text

PDF
812

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CONWAY J. A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation. 1963 Apr;27(4 Pt 1):520–529. doi: 10.1161/01.cir.27.4.520. [DOI] [PubMed] [Google Scholar]
  2. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  3. DOYLE A. E., FRASER J. R., MARSHALL R. J. Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sci. 1959 Aug;18:441–454. [PubMed] [Google Scholar]
  4. Egan B., Neubig R., Julius S. Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther. 1985 Nov;38(5):519–524. doi: 10.1038/clpt.1985.217. [DOI] [PubMed] [Google Scholar]
  5. Esler M. D., Julius S., Randall O. S., Ellis C. N., Kashima T. Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol. 1975 Oct 31;36(5):708–715. doi: 10.1016/0002-9149(75)90173-3. [DOI] [PubMed] [Google Scholar]
  6. Esler M., Julius S., Zweifler A., Randall O., Harburg E., Gardiner H., DeQuattro V. Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med. 1977 Feb 24;296(8):405–411. doi: 10.1056/NEJM197702242960801. [DOI] [PubMed] [Google Scholar]
  7. FREIS E. D. Hemodynamics of hypertension. Physiol Rev. 1960 Jan;40:27–54. doi: 10.1152/physrev.1960.40.1.27. [DOI] [PubMed] [Google Scholar]
  8. Folkow B. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med Suppl. 1978 Dec;4:3s–22s. doi: 10.1042/cs055003s. [DOI] [PubMed] [Google Scholar]
  9. Goldstein D. S., McCarty R., Polinsky R. J., Kopin I. J. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension. 1983 Jul-Aug;5(4):552–559. doi: 10.1161/01.hyp.5.4.552. [DOI] [PubMed] [Google Scholar]
  10. Goldstein D. S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension. 1983 Jan-Feb;5(1):86–99. doi: 10.1161/01.hyp.5.1.86. [DOI] [PubMed] [Google Scholar]
  11. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  12. Harper R. N., Moore M. A., Marr M. C., Watts L. E., Hutchins P. M. Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res. 1978 Nov;16(3):369–372. doi: 10.1016/0026-2862(78)90070-5. [DOI] [PubMed] [Google Scholar]
  13. Hulthén U. L., Bolli P., Bühler F. R. Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man. Br J Clin Pharmacol. 1985;20 (Suppl 1):62S–66S. doi: 10.1111/j.1365-2125.1985.tb05144.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Korner P. I., West M. J., Shaw J., Uther J. B. "Steady-state" properties of the baroreceptor-heart rate reflex in essential hypertension in man. Clin Exp Pharmacol Physiol. 1974 Jan-Feb;1(1):65–76. doi: 10.1111/j.1440-1681.1974.tb00528.x. [DOI] [PubMed] [Google Scholar]
  15. Lockette W., Otsuka Y., Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 1986 Jun;8(6 Pt 2):II61–II66. doi: 10.1161/01.hyp.8.6_pt_2.ii61. [DOI] [PubMed] [Google Scholar]
  16. Matsuda H., Kuon E., Holtz J., Busse R. Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha 2-adrenergic agonists. J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):680–688. doi: 10.1097/00005344-198507000-00011. [DOI] [PubMed] [Google Scholar]
  17. Meier A., Weidmann P., Grimm M., Keusch G., Glück Z., Minder I., Ziegler W. H. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension. Hypertension. 1981 May-Jun;3(3):367–372. doi: 10.1161/01.hyp.3.3.367. [DOI] [PubMed] [Google Scholar]
  18. Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977 Sep 1;21(5):625–636. doi: 10.1016/0024-3205(77)90070-4. [DOI] [PubMed] [Google Scholar]
  19. Philipp T., Distler A., Cordes U. Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet. 1978 Nov 4;2(8097):959–963. doi: 10.1016/s0140-6736(78)92526-6. [DOI] [PubMed] [Google Scholar]
  20. Prewitt R. L., Chen I. I., Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 1982 Aug;243(2):H243–H251. doi: 10.1152/ajpheart.1982.243.2.H243. [DOI] [PubMed] [Google Scholar]
  21. Short D. Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J. 1966 Mar;28(2):184–192. doi: 10.1136/hrt.28.2.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand Suppl. 1970;343:1–56. [PubMed] [Google Scholar]
  23. Takeshita A., Mark A. L. Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension. 1980 Sep-Oct;2(5):610–616. doi: 10.1161/01.hyp.2.5.610. [DOI] [PubMed] [Google Scholar]
  24. Wallin B. G., Sundlöf G., Eriksson B. M., Dominiak P., Grobecker H., Lindblad L. E. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand. 1981 Jan;111(1):69–73. doi: 10.1111/j.1748-1716.1981.tb06706.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES